Optimi Health (TSE:OPTI)
:OPTI
Want to see TSE:OPTI full AI Analyst Report?
OPTI Stock Chart & Stats
C$0.32
>-C$0.01(-2.38%)
At close: 4:00 PM EST
C$0.32
>-C$0.01(-2.38%)
Day’s Range― - ―
52-Week RangeC$3.15 - C$12.60
Previous CloseN/A
Volume13.36K
Average Volume (3M)169.72K
Market Cap
C$45.57M
Enterprise ValueC$32.67M
Total Cash (Recent Filing)C$491.75K
Total Debt (Recent Filing)C$6.70M
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Aug 28, 2026EPS Estimate
-0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.25
Shares Outstanding5,625,897
10 Day Avg. Volume137,724
30 Day Avg. Volume169,715
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)5.70
Price to Sales (P/S)87.81
P/FCF Ratio-13.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
GMP-compliant Manufacturing CapabilitiesOwning GMP-capable production and regulated-supply credentials is a durable competitive advantage in controlled substances. It enables long-term contracts with research/clinical customers, supports higher margins for regulated supply, and raises entry barriers versus non‑GMP providers.
Diversified Service Revenue Model (product, CDMO, Analytics)Multiple complementary revenue streams (product sales, CDMO, analytical services) reduce customer-concentration risk and allow cross-selling. CDMO and testing work are structurally sticky with recurring project demand from clinical programs, supporting steadier long‑term cash generation if volumes scale.
Improving Cash Burn Trend Versus Prior YearA material reduction in operating cash outflows signals improving operational control and extends runway without immediate financing. If sustained, this trend lowers refinancing pressure and gives management more time to convert GMP capacity and contracts into positive cash flow.
Bears Say
Very Small, Falling Revenue BaseA tiny and rapidly declining top line undermines scaling and makes fixed-cost absorption difficult. Persistent low revenues constrain the firm’s ability to invest in commercialization or R&D, increase sensitivity to single‑customer losses, and weaken prospects for sustainable profitability.
Negative Gross Profit And Sustained Operating LossesNegative gross margins indicate structural pricing or cost issues at the product/production level. Continued large EBIT losses erode equity and limit reinvestment capacity; until gross margins turn positive, profitability will remain elusive despite operational improvements.
Rising Leverage And Weakened Equity BaseHigher debt and declining equity increase refinancing and covenant risk for a cash-burning company. Elevated leverage raises interest burden, reduces financial flexibility for growth or regulatory compliance investments, and increases likelihood of dilutive capital raises under stress.
Optimi Health News
OPTI FAQ
What was Optimi Health’s price range in the past 12 months?
Optimi Health lowest stock price was C$3.15 and its highest was C$12.60 in the past 12 months.
What is Optimi Health’s market cap?
Optimi Health’s market cap is C$45.57M.
When is Optimi Health’s upcoming earnings report date?
Optimi Health’s upcoming earnings report date is Aug 28, 2026 which is in 86 days.
How were Optimi Health’s earnings last quarter?
Optimi Health released its earnings results on Jun 01, 2026. The company reported -C$0.36 earnings per share for the quarter, the consensus estimate of -C$0.36 by C$0.
Is Optimi Health overvalued?
According to Wall Street analysts Optimi Health’s price is currently Overvalued.
Does Optimi Health pay dividends?
Optimi Health does not currently pay dividends.
What is Optimi Health’s EPS estimate?
Optimi Health’s EPS estimate is -0.4.
How many shares outstanding does Optimi Health have?
Optimi Health has 5,625,897 shares outstanding.
What happened to Optimi Health’s price movement after its last earnings report?
Optimi Health reported an EPS of -C$0.36 in its last earnings report, expectations of -C$0.36. Following the earnings report the stock price went up 2.532%.
Which hedge fund is a major shareholder of Optimi Health?
Currently, no hedge funds are holding shares in TSE:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Optimi Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$56.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
70.45%
12-Months-Change
Fundamentals
Return on Equity
-57.28%
Trailing 12-Months
Asset Growth
1.66%
Trailing 12-Months
Company Description
Optimi Health
Optimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
MediPharm Labs
―
PharmaCielo
―
Rubicon Organics
―
Avicanna
―
Options Prices
Currently, No data available
---